← Back to headlines
FTSE 100 Held Back by AstraZeneca Trial Setback
The FTSE 100 index closed down 16.59 points, with its performance notably impacted by a trial setback experienced by pharmaceutical giant AstraZeneca.
9 Jul, 16:33 — 9 Jul, 16:33
Sources
Showing 1 of 1 sources